GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Cost of Goods Sold

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Cost of Goods Sold : HK$7,044 Mil (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Cost of Goods Sold?

Shandong Weigao Group Medical Polymer Co's cost of goods sold for the six months ended in Jun. 2024 was HK$3,509 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Jun. 2024 was HK$7,044 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shandong Weigao Group Medical Polymer Co's Gross Margin % for the six months ended in Jun. 2024 was 50.88%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Shandong Weigao Group Medical Polymer Co's Inventory Turnover for the six months ended in Jun. 2024 was 1.35.


Shandong Weigao Group Medical Polymer Co Cost of Goods Sold Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Cost of Goods Sold Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,306.37 6,072.69 7,170.54 7,193.59 7,204.09

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,951.11 3,429.49 3,668.78 3,535.31 3,508.72

Shandong Weigao Group Medical Polymer Co Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$7,044 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Weigao Group Medical Polymer Co  (HKSE:01066) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shandong Weigao Group Medical Polymer Co's Gross Margin % for the six months ended in Jun. 2024 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(7143.607 - 3508.719) / 7143.607
=50.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Shandong Weigao Group Medical Polymer Co's Inventory Turnover for the six months ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Shandong Weigao Group Medical Polymer Co Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
Executives
Wei Hai Wei Gao Guo Ji Yi Liao Tou Zi Kong Gu You Xian Gong Si
Wei Gao Ji Tuan You Xian Gong Si
Chen Xueli 2201 Interest of corporation controlled by you

Shandong Weigao Group Medical Polymer Co Headlines

No Headlines